Posts tagged astronauts

Posts tagged astronauts
In an extensive study of sleep monitoring and sleeping pill use in astronauts, researchers from Brigham and Women’s Hospital (BWH) Division of Sleep and Circadian Disorders, Harvard Medical School, and the University of Colorado found that astronauts suffer considerable sleep deficiency in the weeks leading up to and during space flight. The research also highlights widespread use of sleeping medication use among astronauts.
The study, published in The Lancet Neurology on August 8, 2014, recorded more than 4,000 nights of sleep on Earth, and more than 4,200 nights in space using data from 64 astronauts on 80 Shuttle missions and 21 astronauts aboard International Space Station (ISS) missions. The 10-year study is the largest study of sleep during space flight ever conducted. The study concludes that more effective countermeasures to promote sleep during space flight are needed in order to optimize human performance.
"Sleep deficiency is pervasive among crew members," stated Laura K. Barger, PhD, associate physiologist in the BWH Division of Sleep and Circadian Disorders, and lead study author. "It’s clear that more effective measures are needed to promote adequate sleep in crew members, both during training and space flight, as sleep deficiency has been associated with performance decrements in numerous laboratory and field-based studies."
Despite NASA scheduling 8.5 hours of sleep per night for crew members in space flight, the average (mean) duration of sleep during space flight was just under six (5.96) hours on shuttle missions, and just over six hours (6.09) on ISS missions. Twelve percent of sleep episodes on shuttle missions and 24 percent on ISS missions lasted seven hours or more, as compared to 42 percent and 50 percent, respectively, in a post-flight data collection interval when most astronauts slept at home.
Moreover, the results suggest that astronauts’ build-up of sleep deficiency began long before launch, as they averaged less than 6.5 hours sleep per night during the training interval occurring approximately three months prior to space flight.
The research also highlights widespread use of sleeping medications such as zolpidem and zaleplon during space flight. Three-quarters of ISS crew members reported taking sleep medication at some point during their time on the space station, and more than three-quarters (78 percent) of shuttle-mission crew members used medication on more than half (52 percent) of nights in space.
"The ability for a crew member to optimally perform if awakened from sleep by an emergency alarm may be jeopardized by the use of sleep-promoting pharmaceuticals," said Barger. "Routine use of such medications by crew members operating spacecraft are of particular concern, given the U. S. Federal Drug Administration (FDA) warning that patients using sleeping pills should be cautioned against engaging in hazardous occupations requiring complete mental alertness or motor coordination, including potential impairment of performance of such activities that may occur the day following ingestion of sedative/hypnotics. This consideration is especially important because all crew members on a given mission may be under the influence of a sleep promoting medication at the same time."
Charles Czeisler, PhD, MD, FRCP, chief, BWH Division of Sleep and Circadian Disorders, and senior study author, adds: “Future exploration spaceflight missions to the moon, Mars or beyond will require development of more effective countermeasures to promote sleep during spaceflight in order to optimize human performance. These measures may include scheduling modifications, strategically timed exposure to specific wavelengths of light, and behavioral strategies to ensure adequate sleep, which is essential for maintaining health, performance and safety.”
(Source: eurekalert.org)
In the first study of its kind, a team of researchers led by faculty at the Perelman School of Medicine at the University of Pennsylvania and the Baylor College of Medicine, has analyzed data on the impact of prolonged operational confinement on sleep, performance, and mood in astronauts from a groundbreaking international effort to simulate a 520-day space mission to Mars. The findings, published online-first in the Proceedings of the National Academy of Sciences, revealed alterations of life-sustaining sleep patterns and neurobehavioral consequences for crew members that must be addressed for successful adaption to prolonged space missions.
"The success of human interplanetary spaceflight, which is anticipated to be in this century, will depend on the ability of astronauts to remain confined and isolated from Earth much longer than previous missions or simulations," said David F. Dinges, PhD, professor and chief, Division of Sleep and Chronobiology in the Department of Psychiatry at the Perelman School of Medicine, and co-lead author of the new study. "This is the first investigation to pinpoint the crucial role that sleep-wake cycles will play in extended space missions."
The 520-day simulation, which was developed by the Institute for Biomedical Problems (IBMP) of the Russian Academy of Sciences, and sponsored in part by the European Space Agency (ESA), was initiated on June 3, 2010 when the hatches were closed on a 550-cubic-meter IBMP spacecraft-like confinement facility in Russia. The simulated mission, involving an international, six-man team of volunteers, involved more than 90 experiments and realistic scenarios to gather valuable psychological and medical data on the effects of a long-term deep space flight. The 520-day mission was broken into three phases: 250 days for the trip to Mars, 30 days on the surface, and 240 days for the return to Earth.
“As the only U.S. research team involved with the Mars 520-day simulation, the study required international coordination and strong collaborations to ensure that the experiments were conducted in a thorough and rigorous manner,” said Jeffrey P. Sutton, MD, PhD, professor and director, Center for Space Medicine at Baylor College of Medicine, and senior study author. The investigators monitored the crew’s rest-activity patterns, performance and psychological responses to determine the extent to which sleep loss, fatigue, stress, mood changes and conflicts occurred during the mission.
Measurements included continuous recordings of body movements using wrist actigraphy (a noninvasive means of estimating sleep and movement intensity), and light exposure and weekly computer-based neurobehavioral assessments to identify changes in the crew’s activity levels, sleep quantity and quality, sleep–wake intervals, alertness performance, and workload throughout the 17 months of mission confinement.
Data from the actigraph devices revealed that crew sedentariness increased across the mission, as illustrated by decreased waking movement and increased sleep and rest times. The majority of crewmembers also experienced one or more disturbances of sleep quality, alertness deficits, or altered sleep–wake intervals and timing, suggesting inadequate circadian synchronization.
"Taken together, these measurements point to the need to identify markers of differential vulnerability to abnormal decrease in muscular movement and sleep– wake changes in crew members during the prolonged isolation of exploration spaceflight and the need to ensure maintenance of the Earth’s natural circadian rhythm, sleep quantity and quality, and optimal activity levels during exploration missions," said Mathias Basner, MD, PhD, MSc, assistant professor of Sleep and Chronobiology in Psychiatry at Penn, and co-lead author.
The research team concludes that successful adaptation to such missions will require crews to transit in spacecraft and live in surface habitats that artificially mimic aspects of Earth’s sleep-wake activity cycles, such as appropriately timed light exposure, food intake, and exercise. This dynamic will be necessary to maintain neurocognition and human behavior throughout the flight.
Houston, We Have Another Problem: Study Shows that Space Travel is Harmful to the Brain
As if space travel was not already filled with enough dangers, a new study out today in the journal PLOS ONE shows that cosmic radiation – which would bombard astronauts on deep space missions to places like Mars – could accelerate the onset of Alzheimer’s disease.
“Galactic cosmic radiation poses a significant threat to future astronauts,” said M. Kerry O’Banion, M.D., Ph.D., a professor in the University of Rochester Medical Center (URMC) Department of Neurobiology and Anatomy and the senior author of the study. “The possibility that radiation exposure in space may give rise to health problems such as cancer has long been recognized. However, this study shows for the first time that exposure to radiation levels equivalent to a mission to Mars could produce cognitive problems and speed up changes in the brain that are associated with Alzheimer’s disease.”
While space is full of radiation, the earth’s magnetic field generally protects the planet and people in low earth orbit from these particles. However, once astronauts leave orbit, they are exposed to constant shower of various radioactive particles. With appropriate warning, astronauts can be shielded from dangerous radiation associated with solar flares. But there are also other forms of cosmic radiation that, for all intents and purposes, cannot be effectively blocked.
Because this radiation exists in low levels, the longer an astronaut is in deep space, the greater the exposure. This is a concern for NASA as the agency is planning manned missions to a distant asteroid in 2021 and to Mars in 2035. The round trip to the red planet, in particular, could take as long as three years.
For over 25 years, NASA has been funding research to determine the potential health risks of space travel in an effort to both develop countermeasures and determine whether or not the risks warranted sending men and women on extended missions in deep space.
Since that time, several studies have demonstrated the potential cancer, cardiovascular, and musculoskeletal impact of galactic cosmic radiation. The study out today for the first time examines the potential impact of space radiation on neurodegeneration, in particular, the biological processes in the brain that contribute to the development of Alzheimer’s disease. O’Banion – whose research focuses on how radiation affects the central nervous system – and his team have been working with NASA for over eight years.
The researchers studied the impact of a particular form of radiation called high-mass, high-charged (HZE) particles. These particles – which are propelled through space at very high speeds by the force of exploding stars – come in many different forms. For this study the researcher chose iron particles. Unlikely hydrogen protons, which are produced by solar flares, the mass of HZE particles like iron, combined with their speed, enable them to penetrate solid objects such as the wall and protective shielding of a spacecraft.
“Because iron particles pack a bigger wallop it is extremely difficult from an engineering perspective to effectively shield against them,” said O’Banion. “One would have to essentially wrap a spacecraft in a six-foot block of lead or concrete.”
Neuroscientist keeps astronauts awake with ISS lighting tweaks
A neuroscientist is working with Nasa to develop special lamps that could help restore the circadian rhythm of exhausted astronauts working aboard the International Space Station (ISS).
Thomas Jefferson University neuroscientist George C Brainard, who has headed up the university’s Light Research Program since 1984, received approval for the lights in early 2012 and 100 of the LED models are due to be sent to Nasa by mid-2015. The lights have three different colour temperatures to help ease the astronauts into morning, nighttime and normal working mode.
"An astronaut here on Earth experiences a 24-hour day/night cycle just like you and I," explained Brainard. "Now when they’re on the space station, they’re circling the planet every 90 minutes. So they’ve gone from a 24-hour day to a 90-minute day."